Delivery Order SPE2DB22D1202-SPE2DB25FVKL0
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,950.76 for Candesartan Cilexetil 8 mg tablets (90-count) on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $1,113.48 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Candesartan Cilexetil 8 mg tablets (90-count) with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contracting relationship. The pharmaceutical will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $16,479.99 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 8 mg tablets (90-count) on September 18, 2025, with completion expected by September 19, 2025. This delivery order was competitively awarded without any set-aside designation and utilizes firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,337.06 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on June 2, 2025, with completion scheduled for June 3, 2025. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, indicating competitive award. The product will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,350.69 on September 16, 2025, for the supply of Candesartan Cilexetil 8 mg tablets (90-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 17, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $10,881.52 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles). This competitively awarded, firm fixed-price contract, with no set-aside designation, was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $18,323.79 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count units). This competitively awarded, firm fixed price delivery order was issued on July 15, 2025, with an ultimate completion date of July 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating the award was...
- The Defense Logistics Agency awarded a delivery order valued at $2,224.30 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 8 mg tablets (90-count) on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract represents a firm fixed price, non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle designed to support global...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, for the supply of Candesartan Cilexetil 8 mg tablets (90-count) with a ceiling value of $1,143.34. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $1,175.41. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKL0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,060.74 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 8 mg tablets (90-count) with a firm fixed price structure. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025, and represents a non-set-aside, competitively awarded contract. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and conducts extensive pharmaceutical distribution operations for federal medical procurement. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen consistently delivers both brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/5/25 |